We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Orthofix Medical
OFIX
$419M
| $2.23M | ﹤0.01% |
58,629
-6,951
| -11% | -$277K |
|
1852
Revolution Medicines
RVMD
$44B
| $2.22M | ﹤0.01% |
80,810
+2,609
| +3% | +$75.9K |
|
1853
Rocket Companies
RKT
$38.9B
| $2.22M | ﹤0.01% |
138,330
+20,029
| +17% | +$350K |
|
1854
TriMas Corp
TRS
$1.44B
| $2.22M | ﹤0.01% |
68,501
+1,975
| +3% | +$61K |
|
|
DVAX
1855
DELISTED
Dynavax Technologies
DVAX
| $2.22M | ﹤0.01% |
115,352
+4,244
| +4% | +$56.4K |
|
|
PR
1856
Permian Resources
PR
$16.9B
| $2.21M | ﹤0.01% |
330,120
+69,989
| +27% | +$382K |
|
1857
ProPetro Holding
PUMP
$1.35B
| $2.21M | ﹤0.01% |
255,530
-25,183
| -9% | -$197K |
|
1858
Enterprise Financial Services Corp
EFSC
$2.39B
| $2.21M | ﹤0.01% |
48,781
+10,643
| +28% | +$477K |
|
1859
SkinHealth Systems
SKIN
$85.7M
| $2.2M | ﹤0.01% |
84,816
+39,694
| +88% | +$873K |
|
|
GPMT
1860
Granite Point Mortgage Trust
GPMT
$61.2M
| $2.2M | ﹤0.01% |
166,849
-21,880
| -12% | -$301K |
|
1861
Designer Brands
DBI
$333M
| $2.2M | ﹤0.01% |
157,659
-20,337
| -11% | -$294K |
|
|
CTEV
1862
Claritev Corp
CTEV
$556M
| $2.19M | ﹤0.01% |
9,738
-2,920
| -23% | -$790K |
|
1863
Tactile Systems Technology
TCMD
$665M
| $2.19M | ﹤0.01% |
49,318
-9,580
| -16% | -$431K |
|
1864
HealthStream
HSTM
$840M
| $2.19M | ﹤0.01% |
76,615
-9,301
| -11% | -$272K |
|
1865
Artivion
AORT
$1.32B
| $2.19M | ﹤0.01% |
98,212
-14,139
| -13% | -$364K |
|
1866
Sinclair Inc
SBGI
$1.03B
| $2.19M | ﹤0.01% |
69,074
+1,107
| +2% | +$32.6K |
|
1867
Kforce
KFRC
$1.06B
| $2.19M | ﹤0.01% |
36,666
+2,547
| +7% | +$154K |
|
1868
Central Pacific Financial
CPF
$1B
| $2.18M | ﹤0.01% |
84,887
-10,527
| -11% | -$264K |
|
1869
1st Source
SRCE
$2.12B
| $2.18M | ﹤0.01% |
46,128
+12,210
| +36% | +$556K |
|
|
AGR
1870
DELISTED
Avangrid, Inc.
AGR
| $2.18M | ﹤0.01% |
44,813
-3,923
| -8% | -$207K |
|
1871
Sotera Health
SHC
$5.38B
| $2.17M | ﹤0.01% |
82,870
+14,652
| +21% | +$354K |
|
1872
Acadia Pharmaceuticals
ACAD
$5.03B
| $2.16M | ﹤0.01% |
130,173
+1,651
| +1% | +$31.8K |
|
1873
Inogen
INGN
$164M
| $2.15M | ﹤0.01% |
49,938
-4,618
| -8% | -$284K |
|
|
PENG
1874
Penguin Solutions Inc
PENG
$2.99B
| $2.15M | ﹤0.01% |
96,684
+18,752
| +24% | +$449K |
|
1875
ChargePoint
CHPT
$161M
| $2.15M | ﹤0.01% |
5,373
-486
| -8% | -$226K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.